Table 1 Current approval of the NOACs
From: The role of prothrombin complex concentrates in reversal of target specific anticoagulants
| Â | FDA Approval | EMA Approval |
|---|---|---|
Dabigatran | -Stroke prevention in AF | -VTE prevention after orthopedic surgery, |
-Stroke prevention in AF | ||
Rivaroxaban | -Stroke prevention in AF, | -VTE prevention afte orthopedic surgery |
-VTE prevention after orthopedic surgery | -Stroke prevention in AF | |
- VTE treatment | ||
Apixaban | -Stroke prevention in AF | -VTE prevention after orthopedic surgery |
-Stroke prevention in AF |